相关实验视频

Updated: Jun 26, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

德斯莫伊德瘤初始治疗的演变

Alex J Bartholomew1, Kristen E Rhodin2, Laura Noteware2

  • 1Department of Surgery, Duke University School of Medicine, Durham, NC, USA. alex.bartholomew@duke.edu.

Annals of surgical oncology
|August 12, 2024
PubMed
概括

积极监测越来越多地成为desmoid瘤 (DTs) 的首选初始治疗方法,反映了传统手术的转变. 这种方法与当前的专家建议相一致,用于管理这些局部侵略性的非转移性纤维细胞瘤.

关键词:
积极监视活动的积极监视.通过冷除,可以进行冷除.这种瘤是Desmoid瘤.最初的治疗方法.没有治疗的生存率.铁氨酸激酶抑制剂 铁氨酸激酶抑制剂

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...